Feasibility & Site Selection

Evidence-based feasibility in 5–7 business days so you choose sites that will actually recruit.

Unrealistic feasibility is one of the most common reasons studies fall behind. Our feasibility process combines protocol analysis with real patient-pool data and direct investigator interviews.

Our feasibility approach

We review inclusion and exclusion criteria against site patient databases, assess competing studies, evaluate infrastructure and staff, and provide realistic enrollment projections for each proposed site.

What is included

  • Protocol and eligibility criteria review
  • Patient-pool and competing-study analysis
  • Investigator interest and experience assessment
  • Infrastructure and equipment checks
  • Realistic enrollment projections
  • Pre-study and site qualification visits

Frequently asked questions

How quickly can you deliver feasibility?

We usually deliver a site-by-site feasibility assessment with realistic enrollment projections within five to seven business days of receiving a protocol synopsis under NDA.

Do you support medical device investigations?

Yes. We support pilot, pivotal and post-market clinical investigations of medical devices and in-vitro diagnostics in line with the Medical Devices Rules, 2017.

Can you work with overseas sponsors and CROs?

Absolutely. We regularly act as the local execution partner for international sponsors and CROs, supporting regulatory submissions, site management and monitoring in India.

What does your quality system look like?

We operate under a documented quality management system with SOPs, training records, internal audits, CAPA management and regular mock inspections at sites.

Ready to start your next study in India?

Share your protocol synopsis and we will return a site feasibility assessment and start-up plan — confidentially and within five business days.

  • Confidential review under NDA
  • Response within one business day
  • Direct PI and site assessment